Korean J Fam Med Search

CLOSE


Korean J Fam Med > Volume 39(5); 2018 > Article
Sandoughi, Fazeli, Naseri-Ramroudi, and Barzkar: Best Practice for Prolonged Fever in Primary Care Setting: Close Follow-Up or Empiric Antibiotic Therapy?

Abstract

The management of prolonged fever in low-socioeconomic-status areas by primary care providers such as general practitioners is challenging. Given the endemic nature of many infectious diseases, physicians typically start empirical antibiotic therapy following a limited diagnostic workup including serologic examinations. Herein, we report the case of a young male patient with prolonged fever and arthralgia initially diagnosed with and treated for brucellosis but with a confirmed diagnosis of systemic lupus erythematosus on follow-up. This unique case shows that close follow-up is the best practice for managing prolonged fever in cases with non-specific laboratory findings.

INTRODUCTION

Fever is one of the most common symptoms of a wide variety of diseases, including infectious, rheumatologic, and benign and malignant neoplastic diseases. General practitioners and family medicine physicians treat patients in primary care settings. To manage prolonged fever in the primary care setting, many physicians consider the most prevalent endemic infectious diseases and prescribe empirical antibiotic therapy based on serological and other preliminary laboratory study findings. This management strategy is very simple and may be helpful in many circumstances. However, empirical antibiotic therapy may miss some important non-infectious diseases, complicating the patient’s clinical course. Herein we present a case of systemic lupus erythematosus (SLE) that was initially diagnosed as and treated for brucellosis.
SLE, one of the most common rheumatologic disorders, has a wide variety of manifestations [1]. The classic clinical findings may not appear at the initial presentation but may evolve over several months [2]. In addition, the non-specific feature of multi-organ symptoms is another diagnostic challenge that could result in misdiagnosis [3,4].
Brucellosis is a bacterial zoonotic disease manifesting with some non-specific symptoms such as fluctuating fever, night sweats, and joint pain and discomfort. Given the lack of specific clinical signs, brucellosis can mimic other infectious and inflammatory diseases [3].
Some reports have detailed the co-occurrence of SLE and brucellosis [5]. It was also reported that SLE could be misdiagnosed as brucellosis [3]. Positive serology for Brucella may occur in diseases such as typhoid fever, malaria, and lymphoma [6]. However, similar reports on SLE are limited [3]. Furthermore, the positive Brucella serologic findings are common in endemic regions, which can interfere with the diagnosis of other diseases such as SLE [3].
Here we describe the case of a young man who was initially diagnosed with and treated for brucellosis. This case report reviews the potential clinical and laboratory challenges involved in diagnosing SLE in brucellosis-endemic regions.

CASE REPORT

Our patient was an 18-year-old man from the Sistan-Balochestan province in southeastern Iran. He had a 10-day history of prolonged high-grade fever before admission. Other systemic symptoms were fatigue, generalized myalgia, decreased appetite, and nausea. Leg pain and bilateral arthralgia in the knee joints as well as lumbar pain was reported. His family history was unremarkable, and he had administered some antipyretics and analgesics.
The physical examination showed an ill patient with a body temperature >38°C. The head and neck examinations were negative for upper respiratory infection. The heart and lungs were normal. No significant lymphadenopathy or hepatosplenomegaly was found and no skin rashes were noted. The initial rheumatologic examinations were nonspecific.
The routine laboratory examinations were insignificant and the serological and microbiologic studies were non-diagnostic. However, the serology of Brucella was positive with a low titer including Wright test (1/40) and 2ME test (1/20).
Given the regional endemicity and the patient’s occupational history of sheep bearing, the patient was treated for brucellosis. The antibiotic regimen was a combination of doxycycline and rifampin.
Despite the antibiotic therapy, the patient’s persisted. Progressive periorbital and peripheral edema as well as occasional abdominal pain appeared. The patient had no mucocutaneous complaints except some painless oral ulcers. Previous myalgia and arthralgia have been pronounced. The patient was referred to our tertiary care center for further testing.
The physical examinations revealed fever, bilateral periorbital edema, some oral ulcers in the palatal mucosa, erythematous lesions on the lips, and bilateral pitting pedal edema. The systemic findings were otherwise normal. Detailed rheumatologic examinations showed no significant findings except bilateral tenderness of the knee joints.
The complete blood counts and peripheral smears revealed pancytopenia. Increased creatinine was found, but the urinary sediment was blunt and no significant 24-hour proteinuria was detected. The bone marrow aspiration was reactive. The hand X-ray showed no evidence of articular erosion. Echocardiography revealed a mild pericardial effusion without any evidence of endocarditis. Abdominopelvic ultrasound findings were normal.
A repeat serological test for Brucella was positive with a low titer. The evaluations were negative for Salmonellosis and Malaria. No evidence of human immunodeficiency virus (HIV) infection or viral hepatitis was found. Given the clinical findings of pancytopenia, oral ulcers, and pericardial effusion, serological tests for SLE were performed. The results showed an elevated erythrocyte sedimentation rate; positivity for C-reactive protein; positivity for antinuclear antibody and anti-dsDNA; decreased C3, C4, and CH50 levels; low-titer–positive rheumatoid factor; and negativity for anti-cyclic citrullinated peptide antibody. The diagnosis of SLE was confirmed according to the diagnostic criteria of the American College of Rheumatology.
The patient received two 750-mg cycles of pulsed methylprednisolone within the 3 subsequent days. Hydrocortisone 100 mg twice daily and hydroxychloroquine 200 mg daily were considered for maintenance therapy. Treatment with doxycycline and rifampin was continued in conjunction with the pulsed and maintenance therapy.
The patient’s symptoms improved following the administration of glucocorticoids. The hydrocortisone was substituted for by oral prednisolone 20 mg twice daily. The patient was discharged following 14 days of hospitalization on the prior prednisolone, hydroxychloroquine, and antibiotic regimen. At a follow-up visit 2 months after discharge, no evidence of fever, myalgia, arthralgia, oral ulcers, or periorbital and pedal edema was seen. The laboratory examination revealed normal complete blood counts, creatinine and electrolytes, negative urinalysis, and no 24-hour proteinuria. The patient’s stepwise clinical scenario is summarized in Table 1.

DISCUSSION

Making the diagnosis of SLE in regions with a high endemicity of brucellosis may be difficult due to diagnostic challenges [7]. Non-specific initial presentations such as prolonged fever, myalgia, and arthralgia are not helpful findings to differentiate SLE from brucellosis [7,8]. In addition, it may take several days or months before the classical pattern of joint involvement appear [9]. Characteristic clues such as malar and discoid rashes, photosensitivity, and oral ulcers could be absent at presentation [9,10]. Evidence of organ involvement such as raised creatinine, cytopenia, seizure, or psychosis may be found in close follow-up visits [9]. On the other hand, the patient’s socioeconomic context and occupational history can result in the misdiagnosis of brucellosis in endemic regions.
Laboratory pitfalls are another challenge in the diagnosis of SLE in brucellosis-endemic regions. Considering the predisposition to exposure in endemic regions, a low-titer of serologic Brucella on the Wright and 2ME tests may be found [7-10]. Higher serologic titers indicate brucellosis, but low or intermediate titers are not able to differentiate SLE from brucellosis [3].
The serology of brucellosis can reportedly be positive for other diseases such as typhoid fever, malaria, and lymphoma [6]. However, the false-positive serology of brucellosis in SLE patients has not been clearly explained in the literature [3]. In contrast to brucellosis, falsepositivity for antibodies of other infectious diseases such as those caused by cytomegalovirus and Epstein–Barr virus have been reported in SLE patients [11,12]. Similarly, Jian et al. [13] reported the case of an elderly woman with false-positive HIV serology who was diagnosed with SLE.
Given the clinical and laboratory pitfalls associated with diagnosing SLE in brucellosis-endemic regions, it can be concluded that close follow-up is the best practice. The equivocal serologic findings should be confirmed by definite measures such as microbiological cultures.

CONFLICTS OF INTEREST

No potential conflict of interest relevant to this article was reported.

Table 1.
Patient's sequential clinical scenario
Clinical visit Clinical findings
Primary care visit 10-Day prolonged high-grade fever, fatigue, generalized myalgia, decreased appetite, nausea, leg pain, bilateral knee pain, and lumbar pain
Unremarkable physical and laboratory examinations except high-grade fever and low-titer positive serology of brucellosis
Beginning of antibiotic therapy (doxycycline and rifampin)
Referral to tertiary care center Persistent fever despite antibiotic therapy
Occasional abdominal pain, myalgia, and arthralgia
Periorbital edema, oral ulcers, erythematous lesion on the lips, bilateral knee joint tenderness, and pitting pedal edema
Pancytopenia, elevated creatinine, blunt urinary sediment, no significant proteinuria, and mild pericardial effusion
Elevated erythrocyte sedimentation rate, positive C-reactive protein, low-titer positive Brucella serology, positive antinuclear antibody and anti-dsDNA, decreased C3, C4, and CH50, low-titer positive rheumatoid factor, and negative anti-cyclic citrullinated peptide antibody
Confirmed diagnosis of systemic lupus erythematosus according diagnostic criteria of American college of Rheumatology
14-Day hospital stay Pulsed methylprednisone (750 mg per pulse) ×2 cycles
Maintenance therapy (hydrocortisone 100 mg twice daily and hydroxychloroquine 200 mg daily)
Continuation of doxycycline and rifampin
Discharged on prednisolone, hydroxychloroquine, and antibiotic regimen
Follow-up after 2 months Improved symptoms
Normal clinical and laboratory examination findings
Beginning of scheduled follow-up visits

REFERENCES

1. Hall FC, Walport MJ. Systemic lupus erythematosus. Med Int 1998;26:5–11.

2. Pyrpasopoulou A, Chatzimichailidou S, Aslanidis S. Vascular disease in systemic lupus erythematosus. Autoimmune Dis 2012;2012:876456https://doi.org/10.1155/2012/876456.
crossref pmid pmc pdf
3. Ozlece HK, Huseyinoglu N, Aydin E, Gokmen F, Ekinci M, Serim VA. A case of systemic lupus erythematosus with peripheral neuropathy misdiagnosed as brucellosis. J Neuroinfect Dis 2014;5:1000142https://doi.org/10.4172/2314-7326.1000142.

4. Hajiabdolbaghi M, Esmailpour N, Rasoolinejad M, Yaghoobi MH, Manshadi SA. Disseminated tuberculosis imitating systemic lupus erythematosus. Arch Clin Infect Dis 2013;8:e17288. https://doi.org/10.5812/archcid.17288.
crossref
5. Paganelli V, Marrani E, Brambilla A, Becciani S, Giani T, Pagnini I, et al. “Brucellupus” in a boy: challenging SLE diagnosis in childhood. Pediatr Rheumatol 2014;12(Suppl 1): 314.
crossref
6. Mert A, Ozaras R, Tabak F, Bilir M, Yilmaz M, Kurt C, et al. The sensitivity and specificity of Brucella agglutination tests. Diagn Microbiol Infect Dis 2003;46:241–3.
crossref pmid
7. Saha S, Gupta D, Das S. Autoimmune changes in human brucellosis. Int J Biopharm 2013;4:131–4.

8. Massasso D, Gibson K. Brucellosis mimicking Henoch-Schonlein purpura. Med J Aust 2007;186:602–3.
pmid
9. Martinez-Barrio J, Ovalles-Bonilla JG, Lopez-Longo FJ, Gonzalez CM, Montoro M, Valor L, et al. Juvenile, adult and late-onset systemic lupus erythematosus: a long term follow-up study from a geographic and ethnically homogeneous population. Clin Exp Rheumatol 2015;33:788–94.
pmid
10. Drucker AM, Su J, Mussani F, Siddha SK, Gladman DD, Urowitz MB. Prognostic implications of active discoid lupus erythematosus and malar rash at the time of diagnosis of systemic lupus erythematosus: results from a prospective cohort study. Lupus 2016;25:376–81.
crossref pmid
11. Zandman-Goddard G, Berkun Y, Barzilai O, Boaz M, Blank M, Ram M, et al. Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease. Ann N Y Acad Sci 2009;1173:658–63.
crossref pmid
12. Berkun Y, Zandman-Goddard G, Barzilai O, Boaz M, Sherer Y, Larida B, et al. Infectious antibodies in systemic lupus erythematosus patients. Lupus 2009;18:1129–35.
crossref pmid
13. Jian L, Liang W, Zhang Y, Li L, Mei Y, Tan R, et al. Systemic lupus erythematosus patient with false positive results of antibody to HIV: a case report and a comprehensive literature review. Technol Health Care 2015;23 Suppl 1:S99–S103.
crossref pmid


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
AUTHOR INFORMATION
Editorial Office
Room 2003, Gwanghwamun Officia, 92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
Tel: +82-2-3210-1537    Tax: +82-2-3210-1538    E-mail: kjfm@kafm.or.kr                

Copyright © 2018 by Korean Academy of Family Medicine. All rights reserved.

Developed in M2community

Close layer
prev next